Submission Details
| 510(k) Number | K101514 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 02, 2010 |
| Decision Date | July 09, 2010 |
| Days to Decision | 37 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K101514 is an FDA 510(k) clearance for the BD DIRECTIGEN EZ RSV, a Antigen, Cf (including Cf Controls), Respiratory Syncytial Virus (Class I — General Controls, product code GQG), submitted by Becton, Dickinson & CO (La Jolla, US). The FDA issued a Cleared decision on July 9, 2010, 37 days after receiving the submission on June 2, 2010. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3480.
| 510(k) Number | K101514 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 02, 2010 |
| Decision Date | July 09, 2010 |
| Days to Decision | 37 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | GQG — Antigen, Cf (including Cf Controls), Respiratory Syncytial Virus |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 866.3480 |